States face huge budget deficits in the coming months, threatening their ability to maintain health, education and public safety programs.
WASHINGTON-States face huge budget deficits in the coming months, threatening their ability to maintain health, education and public safety programs. The resource squeeze is making it hard for states to implement a host of critical health reform initiatives.
Initiatives include stronger rate review programs, new medical loss ratio (MLR) requirements and health insurance exchanges, mandated by the Patient Protection and Affordable Care Act (PPACA). The reform legislation further calls for states to expand Medicaid programs to cover some 16 million to 20 million additional uninsured individuals, which many local officials consider impossible.
FUNDING SHORTFALLS
A big help has been the $100 billion in additional federal support for Medicaid programs, but that additional money stops July 1, even though Medicaid enrollment has skyrocketed in many states. Medicaid now insures 53 million Americans and accounts for more than $350 billion in annual spending.
The situation has fueled a clamor for relief from state leaders, as seen at the March NGA Washington meeting. President Barack Obama responded by offering earlier access to "super waivers" that would exempt a state from complying with PPACA, the individual mandate and exchange programs-provided its alternative system can meet the new standards and coverage requirements.
"These are interesting times for people in state government," said Susan Voss, Iowa insurance commissioner and president of the National Association of Insurance Commissioners (NAIC), at the National Policy Forum, sponsored by America's Health Insurance Plans (AHIP) last month. States now face "more of a nightmare," she said.
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Inflation Reduction Act: Reforms to Patient Cost-Sharing
September 18th 2023Lower out-of-pocket costs for patients might put upward pressure on drug prices, as manufacturers face less price sensitivity, note Matthew Majewski and Rhett Johnson of Charles River Associates. But they also note that upward pressure on price is likely to be limited to the inflation rate as any additional price increase would need to be paid back to CMS in the form of inflation rebates.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More
Talking PIE, the Act, Before Thanksgiving
November 23rd 2022AMCP CEO Susan A. Cantrell spoke with Managed Healthcare Executive® about Preapproval Information Exchange (PIE) Act of 2022, which would allow drug manufacturers to share information about a drug with payers before the drug is approved. Cantrell says passage of the PIE Act would speed up patient access to new medications.
Read More
Inflation Reduction Act and the Impact on Pharmaceutical Pricing and Investment Decisions
November 21st 2022The reference to “maximum fair price” in the act bodes poorly for manufacturers and suggests more of a take-it-or-leave-it situation rather than a negotiation where clinical evidence would be the prevailing factor in determining price.
Read More